Wegovy (Semaglutide) is a powerful tool for weight loss and appetite control.
Украина, г.Днепр, ул. 25 Сичеславской Бригады (ул. Рыбинская),19 ‑ 120
Украина, г.Днепр, ул. 25 Сичеславской Бригады (ул. Рыбинская),19 ‑ 120

TREATMENT OF INSULIN RESISTANCE: WEGOVY (VEGOVI) DENMARK

Представленная информация о лекарственных средствах предназначена исключительно для ознакомления и не является офертой, рекламой или инструкцией по применению. Продажа, доставка и назначение препаратов через сайт не осуществляются. По вопросам применения препарата вы можете записаться на очный прием или онлайн-консультацию у профильного специалиста нашей клиники.

WEGOVY (VEGOVI) DENMARK

Active ingredient: Semaglutide

WEGOVY (VEGOVI) DENMARK | TREATMENT OF INSULIN RESISTANCE
Wegovy Medication - An Innovative Solution for Combating Obesity

Wegovy is the latest development by the Danish pharmaceutical company Novo Nordisk A/S. This medication is a reliable aid for adults suffering from excess weight. To date, it has gained significant popularity in Europe and the USA. In Ukraine, it can be purchased at our pharmacy, which offers fast online delivery.

Description and Features of Wegovy

Wegovy is a highly effective weight loss medication. Regular use of Wegovy semaglutide helps reduce body weight by more than 15%, which lowers the risk of developing cardiovascular diseases and type 2 diabetes. The medication also improves anthropometric parameters and quality of life.

Mechanism of Action and Indications

Wegovy Semaglutide acts as a receptor agonist, mimicking the hormone glucagon-like peptide, which controls the feeling of appetite. Wegovy is recommended for patients with a body mass index of 27 kg/m² and above, as well as in cases of obesity (index of 30 kg/m² and above). The medication is also suitable for adults with related conditions such as high cholesterol and type 2 diabetes.

Usage and Contraindications

Wegovy is available in the form of an injectable liquid and is administered subcutaneously once a week. The initial dose is 0.25 mg weekly, with a subsequent monthly increase up to 2.4 mg. The medication has contraindications, including type II endocrine tumors and medullary thyroid carcinoma.

Side Effects and Storage

Some side effects may occur, such as nausea and weakness.

Manufacturer:
Novo Nordisk
Denmark

Temperature Range
2-8 °C
Связь с нами
Введите Ваше Ф.И.О.
Введите Ваш номер телефона.
Выберите удобный мессенджер для связи с Вами.
Введите удобное время для связи с Вами.
Введите суть обращения или Ваш вопрос.
Вернуться назад
Заказать обратный звонок